Syndax Pharmaceuticals, Inc. Common Stock (NASDAQ: SNDX) last traded at $19.65, down 0.51% on the session. The quote above updates while this page is open; the figures below are drawn from Syndax Pharmaceuticals, Inc. Common Stock’s own filings and are restated only when a new one is published.
Syndax Pharmaceuticals, Inc. Common Stock trades on NASDAQ under the ticker SNDX. Its market capitalisation is $1.75 billion.
Valuation measures for Syndax Pharmaceuticals, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $1.75B |
|---|---|
| Enterprise value | $2.11B |
| Price / sales | 6.96 |
| Price / book | 116.21 |
| Beta | 0.62 |
Trailing-twelve-month figures tagged in Syndax Pharmaceuticals, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $252.00M |
|---|---|
| Net income (TTM) | -$220.76M |
| EPS (TTM) | -$2.51 |
| Operating margin | -77.05% |
| Return on equity | -1462.12% |
| Cash | $336.48M |
Range and volume for SNDX over the past 52 weeks.
| 52-week high | $25.59 |
|---|---|
| 52-week low | $12.99 |
| Volume | 1.36M |
| Average volume | 1.80M |
| Previous close | $19.75 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.